Celcuity shares fall as launch delay eclipses US approval for breast cancer drug - Reuters
Celcuity shares fall as launch delay eclipses US approval for breast cancer drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNX1pJbjBWT2s0X0RCTFN5dEdyRG93Y0llSE5acllyMlhNek15SENaUjdicjlZanZWUGhlMzktUWdra1ZuVHNyZEx5eXRqUjRreURxaC1icjBKSGR6UnZqdmFoMmdiWnYtd0JoRlU3dTE3UzNmV0ZNZWtUMnJrNmJZU0dtZV9wZTM1cFlfNnZ4RUtvTnFQeWxjUjhzdVozVnkzWTl2RGJPQmRBMUlHRy1vNDNxZnM2bXU5R2V3YTZzdlZYYnJUaHUyUg?oc=5" target="_blank">Celcuity shares fall as launch delay eclipses US approval for breast cancer drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMSuccess after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough Reuters
August 28, 2026 at 11:32 AMBioNTech halts mRNA colorectal cancer vaccine trial after safety review - Reuters
BioNTech halts mRNA colorectal cancer vaccine trial after safety review Reuters
August 28, 2026 at 05:12 PMUS FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
August 28, 2026 at 10:16 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AM